459 related articles for article (PubMed ID: 29510145)
1. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.
Park CH; Kim NH; Park JH; Park DI; Sohn CI; Jung YS
Gastrointest Endosc; 2018 Jul; 88(1):128-135. PubMed ID: 29510145
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of risk stratification models for colorectal cancer based on fecal hemoglobin concentration and clinical risk factors.
Park CH; Jung YS; Kim NH; Park JH; Park DI; Sohn CI
Gastrointest Endosc; 2019 Jun; 89(6):1204-1211.e1. PubMed ID: 30817918
[TBL] [Abstract][Full Text] [Related]
3. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS
Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
Gastrointest Endosc; 2017 Nov; 86(5):892-899. PubMed ID: 28385585
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea.
Kim DH; Cha JM; Shin HP; Joo KR; Lee JI; Park DI
J Clin Gastroenterol; 2015 Jan; 49(1):41-9. PubMed ID: 24583751
[TBL] [Abstract][Full Text] [Related]
6. Prediction of the Risk of a Metachronous Advanced Colorectal Neoplasm Using a Novel Scoring System.
Lee JY; Park HW; Kim MJ; Lee JS; Lee HS; Chang HS; Choe J; Hwang SW; Yang DH; Myung SJ; Yang SK; Byeon JS
Dig Dis Sci; 2016 Oct; 61(10):3016-3025. PubMed ID: 27358228
[TBL] [Abstract][Full Text] [Related]
7. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
8. Yield of repeat colonoscopy in asymptomatic individuals with a positive fecal immunochemical test and recent colonoscopy.
Kim NH; Jung YS; Lim JW; Park JH; Park DI; Sohn CI
Gastrointest Endosc; 2019 May; 89(5):1037-1043. PubMed ID: 30684602
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
[TBL] [Abstract][Full Text] [Related]
10. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D
Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350
[TBL] [Abstract][Full Text] [Related]
11. Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test?
Kim NH; Yang HJ; Park SK; Park JH; Park DI; Sohn CI; Choi K; Jung YS
Dig Dis Sci; 2016 Sep; 61(9):2685-93. PubMed ID: 27107865
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of and risk factors for colorectal neoplasms in young adults in a screening population.
Lee SE; Jo HB; Kwack WG; Jeong YJ; Yoon YJ; Kang HW
World J Gastroenterol; 2016 Mar; 22(10):2981-92. PubMed ID: 26973394
[TBL] [Abstract][Full Text] [Related]
13. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
[TBL] [Abstract][Full Text] [Related]
14. Impact of family history of colorectal cancer on age-specific prevalence of colorectal neoplasia.
Park CH; Kim NH; Park JH; Park DI; Sohn CI; Jung YS
J Gastroenterol Hepatol; 2019 Mar; 34(3):537-543. PubMed ID: 30462856
[TBL] [Abstract][Full Text] [Related]
15. The fecal immunochemical test has high accuracy for detecting advanced colorectal neoplasia before age 50.
Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
Dig Liver Dis; 2017 May; 49(5):557-561. PubMed ID: 28065631
[TBL] [Abstract][Full Text] [Related]
16. Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment Tool.
Imperiale TF; Yu M; Monahan PO; Stump TE; Tabbey R; Glowinski E; Ransohoff DF
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27582444
[TBL] [Abstract][Full Text] [Related]
17. Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average-risk individuals.
Ng SC; Ching JY; Chan VC; Wong MC; Tang R; Wong S; Luk AK; Lam TY; Gao Q; Chan AW; Wu JC; Chan FK; Lau JY; Sung JJ
Aliment Pharmacol Ther; 2015 Jan; 41(1):108-15. PubMed ID: 25339583
[TBL] [Abstract][Full Text] [Related]
18. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M
Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260
[TBL] [Abstract][Full Text] [Related]
19. Long-term risk of colorectal cancer in individuals with serrated polyps.
Holme Ø; Bretthauer M; Eide TJ; Løberg EM; Grzyb K; Løberg M; Kalager M; Adami HO; Kjellevold Ø; Hoff G
Gut; 2015 Jun; 64(6):929-36. PubMed ID: 25399542
[TBL] [Abstract][Full Text] [Related]
20. Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies.
Wong JCT; Chiu HM; Kim HS; Byeon JS; Matsuda T; Kobayashi N; Wu DC; Ong DE; Sung JJY;
Gastrointest Endosc; 2019 Mar; 89(3):607-613.e1. PubMed ID: 30452915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
